eccogene glp-1 Non‐clinical and first‐in‐human characterization of ECC5004/AZD5004, a novel once‐daily, oral small‐molecule GLP‐1 receptor agonist - Haggag - 2025 - Diabetes, Obesity and Metabolism GLP-1s: The Second Serving -
Description
Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) have cardiovascular benefits in type 2 diabetes, but none of the cardiovascular trials studied atrial fibrillation/atrial flutter (AF) as a primary endpoint
Learn how AOD-9604, MOTS-c, Tesamorelin, Semaglutide, and Tirzepatide work
Can you drink alcohol while taking Wegovy pills
Clinical features A 42-yr-old patient with Barretts esophagus underwent repeat upper gastrointestinal endoscopy and ablation of dysplastic mucosa
Eden Health, the modern health platform that connects individuals with licensed providers for personalized metabolic and longevity care, today announced the launch of an integrated treatment tracking feature within its member portal
Results Fifty patients (82% female) were included
